ATE152724T1 - Synthetische verwandlung von bryostatin 2 in bryostatin 1 - Google Patents

Synthetische verwandlung von bryostatin 2 in bryostatin 1

Info

Publication number
ATE152724T1
ATE152724T1 AT91311568T AT91311568T ATE152724T1 AT E152724 T1 ATE152724 T1 AT E152724T1 AT 91311568 T AT91311568 T AT 91311568T AT 91311568 T AT91311568 T AT 91311568T AT E152724 T1 ATE152724 T1 AT E152724T1
Authority
AT
Austria
Prior art keywords
bryostatin
synthetic conversion
synthetic
conversion
converted
Prior art date
Application number
AT91311568T
Other languages
German (de)
English (en)
Inventor
George R Pettit
Original Assignee
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona filed Critical Univ Arizona
Application granted granted Critical
Publication of ATE152724T1 publication Critical patent/ATE152724T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Auxiliary Devices For Music (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
AT91311568T 1990-12-31 1991-12-12 Synthetische verwandlung von bryostatin 2 in bryostatin 1 ATE152724T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/636,212 US5072004A (en) 1990-12-31 1990-12-31 Synthetic conversion of bryostatin 2 into bryostatin 1

Publications (1)

Publication Number Publication Date
ATE152724T1 true ATE152724T1 (de) 1997-05-15

Family

ID=24550938

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91311568T ATE152724T1 (de) 1990-12-31 1991-12-12 Synthetische verwandlung von bryostatin 2 in bryostatin 1

Country Status (10)

Country Link
US (1) US5072004A (fr)
EP (1) EP0496160B1 (fr)
JP (1) JP3225318B2 (fr)
AT (1) ATE152724T1 (fr)
CA (1) CA2057441C (fr)
DE (1) DE69126011T2 (fr)
DK (1) DK0496160T3 (fr)
ES (1) ES2103788T3 (fr)
GR (1) GR3023990T3 (fr)
MX (1) MX9102830A (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7256286B2 (en) * 1999-11-30 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Bryostatin analogues, synthetic methods and uses
ES2314056T3 (es) * 2001-05-02 2009-03-16 Blanchette Rockefeller Neurosciences Institute Activadores de la anhidrasa carbonica para mejorar el aprendizaje y la memoria.
US20050065205A1 (en) * 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
US20080004332A1 (en) * 2002-03-07 2008-01-03 Alkon Daniel L Methods for alzheimer's disease treatment and cognitive enhancement
TW201206425A (en) 2004-05-18 2012-02-16 Brni Neurosciences Inst Treatment of depressive disorders
US20070054890A1 (en) 2005-07-29 2007-03-08 Alkon Daniel L Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning
US7754465B2 (en) * 2006-04-27 2010-07-13 James A Papp Decontamination of biological agents
US20080025961A1 (en) 2006-07-28 2008-01-31 Alkon Daniel L Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory
WO2008100450A2 (fr) 2007-02-09 2008-08-21 Blanchette Rockefeller Neurosciences Institute Effets thérapeutiques de bryostatines, de bryologues et d'autres substances apparentées sur l'altération de la mémoire induite par une ischémie/un accident vasculaire cérébral et une lésion cérébrale
EP3332797A3 (fr) 2007-02-09 2018-08-01 Blanchette Rockefeller Neurosciences Institute Effets thérapeutiques des bryostatines, bryologues et autres substances apparentées sur les troubles de la mémoire et les lésions cérébrales suite à un traumatisme crânien
US20120027687A1 (en) 2010-07-08 2012-02-02 Alkon Daniel L Fatty acid protein kinase c activators and anticoagulant for the treatment of stroke
EP2605773A1 (fr) 2010-08-19 2013-06-26 Blanchette Rockefeller Neurosciences, Institute Traitement de troubles cognitifs associés à des épines dendritiques mettant en uvre des activateurs de pkc
CA2855932A1 (fr) 2011-11-13 2013-05-16 Blanchette Rockefeller Neurosciences Institute Activateurs de pkc et des combinaisons de ceux-ci
WO2016130969A1 (fr) 2015-02-13 2016-08-18 George Robert Pettit Composés silstatine
US20180217163A1 (en) 2015-05-11 2018-08-02 Daniel L. Alkon Treatment of neurodegenerative conditions using pkc activators after determining the presence of the apoe4 allele
WO2019094709A1 (fr) 2017-11-09 2019-05-16 Pettit George R Composés de bétulastatine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4560774A (en) * 1982-11-17 1985-12-24 Arizona State University Macrocyclic lactones
US4611066A (en) * 1984-08-10 1986-09-09 Arizona State University Bryostatins 4 to 8
US4833257A (en) * 1986-07-28 1989-05-23 Arizona Board Of Regents Compositions of matter and methods of using same

Also Published As

Publication number Publication date
ES2103788T3 (es) 1997-10-01
GR3023990T3 (en) 1997-10-31
EP0496160A1 (fr) 1992-07-29
US5072004A (en) 1991-12-10
DE69126011T2 (de) 1997-09-25
DK0496160T3 (da) 1997-07-28
JPH0867683A (ja) 1996-03-12
JP3225318B2 (ja) 2001-11-05
MX9102830A (es) 1992-06-01
DE69126011D1 (de) 1997-06-12
CA2057441C (fr) 2002-06-11
EP0496160B1 (fr) 1997-05-07
CA2057441A1 (fr) 1992-07-01

Similar Documents

Publication Publication Date Title
ATE152724T1 (de) Synthetische verwandlung von bryostatin 2 in bryostatin 1
ES2055131T3 (es) Resinas de poliester disipables en agua y revestimientos preparados a partir de ellas.
GB2168989B (en) Block polyesters and like compounds useful as soil release agents in detergent compositions
MX174467B (es) 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
IE791967L (en) Cyclosporin derivatives
ATE102196T1 (de) Glykosidase-inhibitor salbostatin, verfahren zu seiner herstellung und seine verwendung.
AU581574B2 (en) Fabric treatment to improve dyeability thereof
FR2599049B1 (fr) Procede de fabrication d'un feuillard en zircaloy 2 ou zircaloy 4 partiellement recristallise et feuillard obtenu
IT8622864A1 (it) Procedimento per migliorare la tingibilita' di manufatti tessili tessuti o non tessuti
ATE144238T1 (de) Verwendung von pilzmyzel als bodenhilfsstoff
FR2601021B2 (fr) Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
FI894003A7 (fi) Kalsiumsulfaatin käyttö orgaanisen jätteen fermentoimisen parantamisek si
EP0631616A4 (fr) Microspheres a base d'acide gras, contenant des anterocoques et dstinees a favoriser la croissance et a ameliorer la quantite de la carcasse.
EP0226541A3 (fr) Colorants antihalo
FR2630128B1 (fr) Boites de culture simultanee de micro-organismes aerobies et anaerobies
DE3787499D1 (de) Herstellung eines Plasminogenaktivators.
DK0452085T3 (da) Fremgangsmåde til fremstilling af methylaminer
FR2553562B1 (fr) Generateur d'un produit radioactif ou toxique utilisable notamment comme generateur d'iode radioactif
FR2614680B1 (fr) Absorbeur-stockeur souple d'energie solaire
Thingstad Environmental contaminants in some adult Larus fuscus fuscus from Tarya, an islet on the coast of Soer-Troendelag.
GB8609033D0 (en) Pharmaceutical compositions
FI884293A0 (fi) Foerfarande foer foerhindrande av tillvaext av mikroorganismer i vattenhaltig vaetska.
JPS52132094A (en) Polyester ether polyols
Spourdalakis The contradictions of the short march to power; the origin and development of the Panhellenic Socialist Movement 1974-1984.
SE8604979D0 (sv) "relip" = rehabilitering lett i position

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee